Keyhole limpet hemocyanin (KLH) conjugate vaccines as novel therapeutic tools in malignant disorders K. Schumacher Guest Editorial Pages: R1 - R2
Marine tumor vaccine carriers: structure of the molluscan hemocyanins KLH and HtH Jürgen MarklBernhard LiebJ. Robin Harris Original Paper Pages: R3 - R9
Clinical results of the ID-KLH vaccination with local GM-CSF in patients with follicular lymphomas (published in Nature Med 1999; 5: 1171-1177) Summary of the lecture by L. W. Kwak K. Schumacher Original Paper Pages: R10 - R13
Detection of keyhole limpet hemocyanin (KLH)-specific immune responses by intracellular cytokine assay in patients vaccinated with idiotype-KLH vaccine Sattva S. NeelapuSivasubramanian BaskarLarry W. Kwak Original Paper Pages: R14 - R19
Keyhole limpet hemocyanin conjugate vaccines against cancer: The Memorial Sloan Kettering experience Cristina MusselliPhilip O. LivingstonGovindaswami Ragupathi Original Paper Pages: R20 - R26
Anti-idiotypic antibody (Ab2) vaccines: Coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients Brigitte BirebentTakashi KoidoDorothee Herlyn Original Paper Pages: R27 - R33